Timothy J. Vittorio

ORCID: 0000-0003-3696-5632
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac Structural Anomalies and Repair
  • Cardiovascular and exercise physiology
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Disease and Adiposity
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Imaging and Diagnostics
  • Heart Rate Variability and Autonomic Control
  • Blood Pressure and Hypertension Studies
  • Lipoproteins and Cardiovascular Health
  • COVID-19 Clinical Research Studies
  • Diabetes Treatment and Management
  • Cardiac Valve Diseases and Treatments
  • Potassium and Related Disorders
  • Cardiac Health and Mental Health
  • Hormonal Regulation and Hypertension
  • SARS-CoV-2 and COVID-19 Research
  • Mechanical Circulatory Support Devices
  • Thyroid Disorders and Treatments
  • Long-Term Effects of COVID-19
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Thyroid Cancer Diagnosis and Treatment
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Effects of Exercise

MemorialCare Health System
2018-2024

Icahn School of Medicine at Mount Sinai
2009-2024

Mount Sinai Health System
2021-2024

Montefiore Health System
2019-2024

Unity Health System
2023

Albert Einstein College of Medicine
2002-2022

Montefiore Medical Center
2008-2022

Georgetown University
2022

University of Lagos
2022

Bowen University
2022

Background— Plasma aldosterone levels are elevated in patients with chronic heart failure (CHF) taking angiotensin-converting enzyme (ACE) inhibitors. Elevated may reflect incomplete inhibition of the vascular converting during long-term ACE inhibition. We simultaneously measured plasma and degree CHF. Methods Results— Thirty-four subjects CHF receiving maximum recommended doses inhibitors for a duration 3 to 105 months were studied. The pressor response exogenous angiotensin I (AI) was...

10.1161/01.cir.0000030935.89559.04 article EN Circulation 2002-08-27

A man in his 60s presented to our clinic for worsening exercise capacity, dyspnoea on exertion 18 months and chest pain not associated with exercise. He had medical history of rheumatoid arthritis (RA), Sjogren's syndrome, Raynaud's phenomenon, gastro-oesophageal reflux, dyslipidaemia Parkinson's disease. was hydroxychloroquine (HCQ) RA at the time presentation. nuclear stress test normal. Cardiac angiogram showed left ventricular ejection fraction 55%, normal coronary arteries, systolic...

10.1136/postgradmedj-2017-135236 article EN Postgraduate Medical Journal 2018-01-20

Introduction: In patients with heart failure (HF), end-tidal CO2 pressure (PetCO2) is related to ventricular function at rest and has been shown predict prognosis. However, little known about the association between performance PetCO2 responses exercise. Methods: Forty-eight HF 13 normal subjects underwent cardiopulmonary exercise testing (CPX), while cardiac output other hemodynamic measurements during were obtained using a novel, noninvasive, bioreactance device based on assessment of...

10.1249/mss.0b013e318184c945 article EN Medicine & Science in Sports & Exercise 2008-12-24

The novel severe acute respiratory syndrome viral disease outbreak due to SARS-CoV-2 is a rapidly evolving and represents one of the greatest medical challenges in recent times. It believed that has migrated from bats an intermediate host then humans. This article aims at mechanism management prothrombotic state COVID-19 positive patients. We tried present how virus can induce thromboembolic events incidence these events. also depict anticoagulation patients as well postdischarge plan...

10.1177/17539447211053470 article EN cc-by-nc Therapeutic Advances in Cardiovascular Disease 2021-01-01

The association between hyperuricemia and cardiovascular diseases has been studied for many years. Research shown a link high uric acid levels increased risk of including coronary artery disease hypertension other conditions. Urate-lowering therapy, particularly with xanthine oxidase inhibitors like allopurinol, promising results in reducing blood pressure individuals hypertension. Clinical trials studies have demonstrated significant reductions both systolic diastolic urate-lowering...

10.1177/11795468241239542 article EN cc-by-nc Clinical Medicine Insights Cardiology 2024-01-01

In this study, we assessed the risk factor profile in premature coronary artery disease (CAD) and acute syndrome for adults ≤40 years old.A retrospective chart analysis of 397 patients old admitted from 2005 to 2014 chest pain who underwent arteriography.Of that had undergone arteriography, 54% CAD while 46% normal arteries. When compared with arteries, were more likely smoke tobacco, have dyslipidemia, be diabetic, BMI >30 kg/m(2), a family history male gender.Healthcare intervention...

10.2217/fca-2016-0011 article EN Future Cardiology 2016-08-05
Coming Soon ...